Skip to main content

Table 1 The CCT2 and PDIA3 expression and clinicopathological features of gallbladder SC/ASC and AC

From: Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma

Clinicalpathological features

SC/ASC (n = 46)

AC (n = 80)

χ2

P

Gender

    

male

19(41.3)

26(32.5)

0.986

0.352

female

27(58.7)

54(67.5)

Age (years)

    

≤ 45

3(6.5)

16(20.0)

4.143

0.042

> 45

43(93.5)

64(80.0)

Degree of differentiation

    

well-differentiated

16(34.8)

27(33.8)

8.515

0.014

moderately-Differentiated

24(52.2)

25(31.3)

poorly-differentiated

6(13.0)

28(35.0)

Tumor maximum diameter (cm)

    

≤ 3 cm

20(43.5)

50(62.5)

4.280

0.039

> 3 cm

26(56.5)

30(37.5)

  

Gallbladder stones

    

no

18(39.1)

42(52.5)

2.093

0.148

yes

28(60.9)

38(47.5)

TNM stage

    

I+II

12(26.1)

21(26.3)

0.287

0.866

III

20(33.5)

38(47.5)

IV

14(30.4)

21(26.3)

Lymph node metastasis

    

no

17(37.0)

30(37.5)

0.004

0.952

yes

29(63.0)

50(62.5)

  

Invasion

    

no

16(34.8)

31(38.8)

0.197

0.658

yes

30(62.5)

49(61.3)

Surgical

    

radical

14(30.4)

26(32.5)

0.215

0.898

palliative

18(39.1)

28(35.0)

biopsy

14(30.4)

26(32.5)

average survival time

10.07(4 to 25)

10.34(3 to 27)

0.014

0.906

CCT2

    

-

23(50.0)

31(46.2)

0.165

0.685

+

23(50.0)

49(53.8)

  

PDIA3

    

-

20(43.5)

35(43.7)

0.001

0.976

+

26(56.5)

45(56.3)

 Â